Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) (P2)

This study has been completed.

Sponsor:

Information provided by:

Italian Trial in Medical Oncology

ClinicalTrials.gov Identifier:

NCT00619541

First received: February 11, 2008

Last updated: February 25, 2009

Last verified: February 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2009
Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)

No publications provided by Italian Trial in Medical Oncology

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Petrini I, Lencioni M, Ricasoli M, Iannopollo M, Orlandini C, Oliveri F, Bartolozzi C, Ricci S. Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma. Cancer Chemother Pharmacol. 2012 Mar;69(3):773-80. Epub 2011 Oct 28.

To Top